AAAAAA

   
Results: 1-10 |
Results: 10
A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer
Authors: Hussain, SA Moffitt, DD Glaholm, JG Peake, D Wallace, DMA James, ND
Citation: Sa. Hussain et al., A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer, ANN ONCOL, 12(7), 2001, pp. 929-935
Hepatocellular carcinoma
Authors: Hussain, SA Ferry, DR El-Gazzaz, G Mirza, DF James, ND McMaster, P Kerr, DJ
Citation: Sa. Hussain et al., Hepatocellular carcinoma, ANN ONCOL, 12(2), 2001, pp. 161-172
A phase II study of the bispecific antibody MDX-H210 (anti-HER2 x CD64) with GM-CSF in HER2+advanced prostate cancer
Authors: James, ND Atherton, PJ Jones, J Howie, AJ Tchekmedyian, S Curnow, RT
Citation: Nd. James et al., A phase II study of the bispecific antibody MDX-H210 (anti-HER2 x CD64) with GM-CSF in HER2+advanced prostate cancer, BR J CANC, 85(2), 2001, pp. 152-156
Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy
Authors: Cooke, PW James, ND Ganesan, R Burton, A Young, LS Wallace, DMA
Citation: Pw. Cooke et al., Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy, BJU INT, 85(7), 2000, pp. 829-835
Long-term risk of salvage cystectomy after radiotherapy for muscle-invasive bladder cancer
Authors: Cooke, PW Dunn, JA Latief, T Bathers, S James, ND Wallace, DMA
Citation: Pw. Cooke et al., Long-term risk of salvage cystectomy after radiotherapy for muscle-invasive bladder cancer, EUR UROL, 38(3), 2000, pp. 279-285
Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: Construction and testing of a tissue-specific adenovirus vector
Authors: Latham, JPF Searle, PF Mautner, V James, ND
Citation: Jpf. Latham et al., Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: Construction and testing of a tissue-specific adenovirus vector, CANCER RES, 60(2), 2000, pp. 334-341
Toward a final design for the Birmingham boron neutron capture therapy neutron beam
Authors: Allen, DA Beynon, TD Green, S James, ND
Citation: Da. Allen et al., Toward a final design for the Birmingham boron neutron capture therapy neutron beam, MED PHYS, 26(1), 1999, pp. 77-82
The 'outside-in' outburst of HT Cassiopeiae
Authors: Ioannou, Z Naylor, T Welsh, WF Catalan, MS Worraker, WJ James, ND
Citation: Z. Ioannou et al., The 'outside-in' outburst of HT Cassiopeiae, M NOT R AST, 310(2), 1999, pp. 398-406
A spatially resolved 'inside-out' outburst of IP Pegasi
Authors: Webb, NA Naylor, T Ioannou, Z Worraker, WJ Stull, J Allan, A Fried, R James, ND Strange, D
Citation: Na. Webb et al., A spatially resolved 'inside-out' outburst of IP Pegasi, M NOT R AST, 310(2), 1999, pp. 407-413
CD30 expression in bladder cancer
Authors: Cooke, PW James, ND Ganesan, R Wallace, M Burton, A Young, LS
Citation: Pw. Cooke et al., CD30 expression in bladder cancer, J PATHOLOGY, 188(1), 1999, pp. 38-43
Risultati: 1-10 |